Predicate |
Object |
contentType |
Journal Article|Review |
issn |
0223-5234 |
pageRange |
113006- |
publicationName |
European Journal of Medicinal Chemistry |
startingPage |
113006 |
hasFundingAgency |
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_8d5e98e6bb93db958f7ee7fb1c6c62f3 |
bibliographicCitation |
Korzeniecki C, Priefer R. Targeting KRAS mutant cancers by preventing signaling transduction in the MAPK pathway. European Journal of Medicinal Chemistry. 2021 Feb;211():113006. doi: 10.1016/j.ejmech.2020.113006. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2989-1519 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4586-0405 |
date |
2021-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://doi.org/10.1016/j.ejmech.2020.113006 https://pubmed.ncbi.nlm.nih.gov/33228976 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21651 https://portal.issn.org/resource/ISSN/0223-5234 |
language |
English |
source |
https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
Targeting KRAS mutant cancers by preventing signaling transduction in the MAPK pathway |
discusses |
http://id.nlm.nih.gov/mesh/M0024891 http://id.nlm.nih.gov/mesh/M0301174 http://id.nlm.nih.gov/mesh/M0457532 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D016283Q000235 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D008958 http://id.nlm.nih.gov/mesh/D009154 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D015398Q000187 http://id.nlm.nih.gov/mesh/D047428Q000494 http://id.nlm.nih.gov/mesh/D015394 http://id.nlm.nih.gov/mesh/D016283Q000037 http://id.nlm.nih.gov/mesh/D016283Q000378 http://id.nlm.nih.gov/mesh/D015398Q000235 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6569 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d6ff811e2f4338cfb3363095186a8098 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 |